Drug Database
Back to search

United States· US:64380-752_54fe37e7-293d-5931-e063-6394a90a256c

Methoxsalen

A methoxsalen product containing methoxsalen, registered in United States by Strides Pharma Science Limited. The same ATC class is registered in 2 of our 19 countries.

ATC L01XD10

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedMethoxsalenATCL01XD10REGISTER NO.US:64380-752_54fe37e7…PACKS LISTED1CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about methoxsalenAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Methoxsalen is registered in 2 of 19 countries.

Countries holding a registration under ATC L01XD10 (methoxsalen), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 1 of them publish a price we can compare per daily dose
Search methoxsalen products by name

Methoxsalen · ATC L01XD10

2 / 19 countries

  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
METHOXSALEN
Manufacturer
Strides Pharma Science Limited
Country
United States (US)
ATC code
L01XD10
ATC class
Methoxsalen
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 1

  • ndc11
    64380-752-16

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

151 interactions on record for methoxsalen.

Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check methoxsalen against other medicinesHow interaction checks work

Methoxsalen · interactions on record

151 records

  • 3 severe
  • 148 moderate

Most severe, free to view

  • Aminolevulinic acidL01XD04severe
  • TizanidineM03BX02severe
  • RasagilineN04BD02severe
  • TetracyclineA01AB13moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Methoxsalen in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All methoxsalen products

Authorised across Europe · EMA

The same active substance is authorised in 17 EEA countries. Names it is sold under:

  • Austria · Methoxsalen Macopharma, Methoxsalen S.A.L.F.
  • Belgium · Methoxsalen Macopharma
  • Czechia · Methoxsalen Maco Pharma, Uvadex
  • Germany · Methoxsalen G.L. Pharma, Methoxsalen Macopharma
  • Denmark · Methoxsalen Macopharma, Uvadex
  • Spain · Metoxaleno G. L. Pharma, Metoxaleno Macopharma
  • France · Meladinine, Methoxsalene G.L. Pharma
  • United Kingdom (Northern Ireland) · Methoxsalen G.L. Pharma, Uvadex
  • Greece · Melaoline
  • Hungary · Methoxsalen Macopharma, Uvadex
  • Italy · Metoxsalene G.L. Pharma, Metoxsalene S.A.L.F.
  • Netherlands · Uvadex
  • Norway · Uvadex
  • Poland · Uvadex
  • Portugal · Uvadex
  • Sweden · Uvadex
  • Slovenia · Metoksalen Maco Pharma

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d23ad858-01c1-460e-9b62-250a217eba31
GET /v1/drugs/d23ad858-01c1-460e-9b62-250a217eba31?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "10",
  "substance": "METHOXSALEN",
  "productndc": "64380-752",
  "dosage_form": "CAPSULE, LIQUID FILLED",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA202687",
  "marketing_category": "ANDA"
}
API referenceMCP serverPlans

See everything about methoxsalen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console